These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37052778)

  • 21. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India.
    Poonia K; Thami GP; Bhalla M; Jaiswal S; Sandhu J
    J Cosmet Dermatol; 2019 Feb; 18(1):401-407. PubMed ID: 29774652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Shedding" low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients.
    Miller RC; Abedian S; Lipner SR
    J Am Acad Dermatol; 2023 Sep; 89(3):623-626. PubMed ID: 37245837
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.
    Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM
    Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized Telogen Effluvium Following Hair Transplantation.
    Loh SH; Lew BL; Sim WY
    Ann Dermatol; 2018 Apr; 30(2):214-217. PubMed ID: 29606820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telogen effluvium after allergic contact dermatitis of the scalp.
    Tosti A; Piraccini BM; van Neste DJ
    Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.
    Torres F; Tosti A
    Semin Cutan Med Surg; 2015 Jun; 34(2):67-71. PubMed ID: 26176282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TrichoScan findings in patients with effluvium capillorum.
    Kasumagic-Halilovic E; Ovcina-Kurtovic N; Begovic B
    Skinmed; 2015; 13(2):98-101. PubMed ID: 26137734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
    J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telogen effluvium.
    Harrison S; Sinclair R
    Clin Exp Dermatol; 2002 Jul; 27(5):389-5. PubMed ID: 12190639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women.
    Sinclair R; Jolley D; Mallari R; Magee J
    J Am Acad Dermatol; 2004 Aug; 51(2):189-99. PubMed ID: 15280836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II.
    Werner B; Mulinari-Brenner F
    An Bras Dermatol; 2012; 87(6):884-90. PubMed ID: 23197208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom?
    Öner Ü; Akdeniz N
    Turk J Med Sci; 2022 Feb; 52(1):188-194. PubMed ID: 34688244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.